Benefit of using renal sodium-glucose cotransporter inhibitors 2 (iSGLT-2) in patients with type 2 Diabetes Mellitus and Heart Failure. Acervo Saúde [Internet]. 2020 Sep. 25 [cited 2026 Nov. 3];12(9):e4349. Available from: https://acervomais.com.br/saude/article/view/4349